A new service from Wolters Kluwer Health integrates several of the marketing research firm’s data points into a single source, offering financial analysts and brand managers a new forecasting capability. The product, inThought, was developed in order to streamline forecasting capabilities for drugmakers, to help them understand where developmental drugs, medical devices and therapies are positioned in the market, and what sort of splash they could make in the future.
”With research headcounts down, there’s a fundamental shift in the way analysts and pharma customers want their research delivered,” said Ben Weintraub, director of research, in a statement. “Rather than simply striving to offer more data faster, our approach sifts through the clutter to synthesize what is truly important.”
Clients can use the tool for monitoring global drug developments, and tap into forecasts of approval models for over 300 drugs in development.
From the August 01, 2009 Issue of MM+M - Medical Marketing and Media
